Evidence map›Paper›PMID 34090699›Full record

ArticleVaccine2021

Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.

Tamar Lasky, Ann W McMahon, Wei Hua, Richard Forshee

Open access · greenAbstract readScoping Review
In one paragraph

Article in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tamar LaskyUS Food and Drug Administration, Office of the Commissioner, Silver Spring, Maryland, USA. Electronic address: Tamar.Lasky@fda.hhs.gov.
Ann W McMahonUS Food and Drug Administration, Office of the Commissioner, Silver Spring, Maryland, USA.
Wei HuaUS Food and Drug Administration, Center for Drugs Evaluation and Research, Silver Spring, Maryland, USA.
Richard ForsheeUS Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, Maryland, USA.
United States Food and Drug Administration · USCenter for Biologics Evaluation and Research · US

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

objectiveThis scoping review mapped studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women.

introductionIn the US, two vaccines are recommended for all pregnant women to prevent illness in the infant: inactivated influenza vaccine (recommended since 2004), and the combined tetanus-diphtheria-acellular pertussis (Tdap) vaccine (recommended since 2013). This scoping review maps the studies conducted to date that address questions about pediatric safety and effectiveness of vaccines administered during pregnancy and provides a knowledge base for evaluating the use of RWD to study this issue.

methodsThe scoping review was conducted following a published protocol. Methods included an electronic search of PubMed and Embase, screening of titles and abstracts by two reviewers, and double extraction of data for summary and synthesis. Studies that reported on pregnant women and the effectiveness or safety outcomes in their infants were included.

resultsForty-eight studies met the inclusion criteria of the scoping review protocol using RWD to assess safety or effectiveness of influenza or pertussis vaccinations administered to pregnant women with respect to pregnancy, infant or child outcomes. Detailed information about data sources, linkage of maternal and infant data, and operational definitions for gestational age were largely absent from the majority of studies raising concerns about reproducibility and validity of study findings.

conclusionsA body of literature is available from which to plan and design future studies of vaccination in pregnant women using RWD. This is of intense importance as new vaccines, such as those for COVID-19, become available to the general population via approval or authorization without inclusion of pregnant women in the clinical trials.

Indexed as

COVID-19Diphtheria-Tetanus-acellular Pertussis VaccinesInfluenza VaccinesWhooping CoughChildFemaleHumansInfantPregnancyPregnant PeopleReproducibility of ResultsSARS-CoV-2VaccinationDiphtheria-Tetanus-acellular Pertussis VaccinesInfluenza VaccinesInfantInfluenzaPertussisPregnancyVaccination

Identifiers

PMID34090699
PMCPMC8500552
OpenAlexW3167622171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.